All In Biotech

Free tool

FAERS Monitor: Loreev Xr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214826 or its brand name (Loreev Xr, Lorazepam). Reports on generic versions are filed under their own applications.

Reports

132,454

Serious

104,627

79% of reports

Hospitalization

56,944

Death reported

20,049

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective9,356
  • fatigue9,067
  • nausea8,908
  • off label use7,927
  • diarrhoea7,263
  • dyspnoea6,330
  • vomiting6,047
  • headache5,884
  • dizziness5,685
  • anxiety5,680
  • pain5,632
  • death4,866
  • asthenia4,820
  • fall4,791
  • pyrexia4,462

Reports by year received

View as table
YearReports
20041,777
20052,009
20061,920
20071,850
20082,103
20092,447
20103,536
20113,806
20124,683
20133,797
20144,705
20157,017
20167,670
20178,448
201810,305
201910,135
20209,963
20218,953
20228,543
20237,941
20248,189
20257,553
20265,100

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,921,705 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anxietySignal5,6803.23.18,601
fallSignal4,7912.32.23,542
pyrexiaSignal4,4622.12.02,446
vomitingSignal6,0472.12.03,310
astheniaSignal4,8202.02.02,601
fatigue9,0671.91.83,695
dizziness5,6851.81.82,123
nausea8,9081.81.83,229
diarrhoea7,2631.81.82,611
dyspnoea6,3301.81.72,217
headache5,8841.51.5984
pain5,6321.51.4833
off label use7,9271.41.41,108
drug ineffective9,3561.11.1144
death4,8660.90.960

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.